Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention.
Phase of Trial: Phase III
Latest Information Update: 22 May 2012
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Therapeutic Use
- 22 May 2012 Actual patient number 187 added as reported by ClinicalTrials.gov.
- 22 May 2012 Actual end date May 2012 added as reported by ClinicalTrials.gov.
- 22 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.